The Financial Analysis and Reporting team at Sarah Cannon Research Institute is responsible for providing comprehensive financial insights and strategic support to enhance the organization's operational efficiency. This team manages budgeting, forecasting, and financial reporting processes, ensuring alignment with clinical trial objectives while maintaining compliance with regulatory standards. By analyzing financial data and performance metrics, they facilitate informed decision-making that contributes to the advancement of oncology research and drug development initiatives.
Amber Woodward-Smith
CFO
Aurora MacDougall
Director Of Finance
Cody Sanders
Manager, Financial Planning An...
Daniel Tiesler
Sr. Director Of Finance
Jed Riley
Manager, Financial Reporting/a...
Justin Aguilar
Manager, Financial Planning An...
Roseann Scully
Director,financial Systems
Tim Diamond
Associate Director Of Accounti...
Towanda G.
Site Financial Analyst
Wesley Harlan
Senior Financial Analyst
View all